This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.
Cannabis isn't an antiviral medication,' says a leading cannabinoid physician. 'It The data look dubious appeared first on Leafly. It doesn't really function that way.'. The post Can cannabis prevent or cure the coronavirus?
The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management.
There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. However, this data was based solely on preclinical findings.
CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. While CBN is often marketed as “the sleep cannabinoid ,” the reality is more complicated.
The combination of minor cannabinoids THCV and CBG could help reduce bad eating habits like snacking and late-night binge eating, according to real-world data (RWD) collected from Cannigma readers last month. But the decrease in appetite is not just seen in the data – it’s also part of the lived experience.
New scientific data shows that CBD interacts directly with the CB1 cannabinoid receptor in ways that are therapeutically relevant while modulating the psychoactive effects of THC. CBD lowers the ceiling on the ability of THC and endogenous cannabinoids to stimulate CB1.
Their data suggests that ADHD causes later cannabis use, which may support the notion that THC is used to self medicate (although ADHD is associated with heavier use of many drugs). Cannabinoid crystals. Across political boundaries, a group of scientists from Russia, China, and the USA crystallized the CB2 cannabinoid receptor.
The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.
Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care. An abstract of the study, “Matched pilot study examining cannabis-based dronabinol for acute pain following traumatic injury,” is online here.
Published in the Journal of Medical Internet Research, the fresh data suggests that the cannabinoids found in cannabis, such as THC and CBD , may have potential as a treatment for sleep deprivation. Treating Insomnia With Cannabinoids.
The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.
BY NORML Analysis: Marijuana Use Data Fails to Support “Gateway Hypothesis” POSTED ON MAY 6, 2021 Boise, Idaho: Claims that the initiation of marijuana use is independently linked to the later use of other controlled substances are not supported by longitudinal data, according to a study published in the Journal of Experimental Criminology.
Synthetic cannabis and cannabinoids have been connected to adverse effects time and time again. When it comes to synthetic or semi-synthetic cannabinoids, consumers are often unaware of the potential risks that come with consuming such forms of cannabis. Examples of these are delta-8 THC , delta-10 THC , and HHC. .
Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.
When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. EG: Right, yeah.
According to data compiled by the US Centers for Disease Control, the drug was attributed to over 11,500 overdose deaths in 2017. Full text of the study, “Reduction of benzodiazepine use in patients prescribed medical cannabis,” appears in the journal Cannabis and Cannabinoid Research here.
New scientific data shows that CBD interacts directly with the CB1 cannabinoid receptor in ways that are therapeutically relevant while modulating the psychoactive effects of THC. CBD lowers the ceiling on the ability of THC and endogenous cannabinoids to stimulate CB1.
NORML has previously written on the data showing a multi-directional association between cannabis and psychiatric illnesses, and we have cautioned that those predisposed to psychosis or other disorders may be at higher risk for adverse events.
State regulators licensed farmers and researchers to cultivate over 500,000 total acres of industrial hemp in the first half of 2019, according to data compiled by the organization VoteHemp.com. percent THC) and products containing cannabinoids derived from hemp from the federal Controlled Substances Act.
The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.
While initial cases of the phenomenon were associated with consumption of cannabinoid oil products via the use of unregulated vapor cartridges , the CDC reports that some cases have also been linked to the use of nicotine only. Three people have died as a result of the illness, and a fourth death is under investigation. .”
Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids. Is that because CBG is a precursor for the other plant cannabinoids?
.–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). About Realm of Caring.
But newer research, including from this year, has indicated that cannabinoid suppositories do have clinical utility, and real-world data collected recently from Cannigma users shows that a CBD product based on a full extract cannabis oil (FECO) can significantly improve menstrual symptoms. absorption), at least with rectal insertion.
Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.
So it’s not surprising that products that combine cannabis and melatonin are making their way into legal marketing – and according to real world data gathered in a recent campaign on The Cannigma, it’s a winning combination. What’s in FOCL’s DEEP SLEEP, Full Spectrum+ Gummies? So what’s in these gifted gummies?
In the first part of this series, we reviewed recent research into the role of the CB2 cannabinoid receptor in cancer proliferation. After all, the CNS is the domain of its sibling, the CB1 cannabinoid receptor — the primary target of THC and the mediator of cannabis’ intoxicating effects. Synthesis of cannabinoid acids.”
Even if a cannabinoid has shown promise on one cancer line, that doesn’t mean it will work for all cancers – even if it’s within the same organ system. Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies.
Journaling can make cannabis use more mindful, deliberate and based on goals, past experiences, and your own personally cultivated data tracking what works best for you. Cannabinoid and terpene profile Recording the THC, CBD, and other cannabinoid conten t of your cannabis product is crucial. But don’t stop there.
“But we can assure them with good information about how their symptoms may improve and how their quality of life may improve with cannabinoid formulations and drugs.”. That understanding is only one of the major shifts happening in medicine with regards to cannabis and cannabinoid research. seventyfour74/123rf). Shutterstock).
The research findings of the study, entitled “A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health,” was published this week in the journal Cannabis and Cannabinoid Research , Volume X, Number X, 2020. Study Findings.
We know that cannabinoids like THC and CBD are fat soluable. In other words, ketogenesis seemed to increase the responsiveness of the ECS and the overall number of cannabinoid receptors within the intestines. Cannabinoids and their metabolites are stored primarily in fat cells. Read more here. It’s really a match made in heaven.
— writer Malcolm Gladwell focused on a 2017 report by the National Academy of Medicine that examined the scientific evidence of the health effects and therapeutic purposes of cannabis and cannabinoids. Not everyone in the field of cannabis and cannabinoid research was put off by the articles. In 2017, for example, Washington had 304.5
Statin medications deplete cannabinoid receptor function, according to a recent study by a team of distinguished Italian scientists. More troublesome, though, is that simvastatin alters genes involved in regulating cannabinoid receptors. Simvastatin also reduces cannabinoid receptor expression.
The European Journal of Pharmacology stated that this effect “ may represent a novel route for molecular regulation of endogenous cannabinoid activity.” When terpenes and cannabinoids interact together, there is a heightened efficacy for medical marijuana patients. They termed this the “Entourage Effect.” Dogwalker OG.
When you smoke cannabis, the cannabinoids enter the bloodstream through your lungs and throat, while edibles are metabolized inside the gut. Topical solutions can activate the cannabinoid receptors in the epidermis, but they do not penetrate deeply into the skin, so they’re most effective for localized treatment.
The plan follows two reports to Congress last year (which the Perkins Coie Cannabis Industry Group has previously written about here and here ) on the safety and labeling of products containing cannabidiol (CBD) and a public statement from outgoing FDA leadership in early 2021 seeking better data for a better understanding of CBD safety.
Technology-enabled clinical research company People Science is carrying out a study into the effects of cannabinoids on sleep behavior. million, People Science plans to invest in ongoing R&D on cannabis, cannabinoids, the microbiome, psychedelics, and digital health interventions. The company is now sitting on $8.5
More than likely, the effects of cannabinoids like CBD and THC are altered during the ketogenic diet, but unfortunately there has been very little research on this topic. This would hypothetically correlate with the altered effects of cannabinoids like THC and CBD, but the study did not look at that. As per usual, more data is needed.
Recent scientific studies suggest that different cannabinoids and other cannabis-derived molecules (e.g Researchers are still in the early stages of learning how exactly cannabinoids affect skin health, but some of the results are compelling. Since then, numerous studies have explored cannabinoid activity in the different skin layers.
The cannabinoid receptor CB1, primary target of THC in the brain, is known for mediating the cannabis high. Project CBD’s recent article on the passing of Raphael Mechoulam noted that the esteemed scientist believed CB2 should be a focus of future cannabinoid science. International journal of molecular sciences vol.
Quemarr Moatamedi School: University of Montana Major/Program: Linguistics and Anthropology Innovation: Emulsion-Based Edibles: Harnessing Anti-Diabetic Cannabinoids in Diabetes Management. Quemarr presents an emulsion-based drug delivery system tailored for cannabinoids and made to tackle America’s diabetes crisis.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content